Related Experiment Video
Updated: Jun 18, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Maintained Symptom Control Following a Shortage-Driven Switch to Immediate-Release Dextroamphetamine: A Case Report
Daniel Singer1, Priti M Kothari2,3
1College of Liberal Arts and Sciences, University of Florida, Gainesville, USA.
Amid stimulant shortages for Attention Deficit Hyperactivity Disorder (ADHD), immediate-release dextroamphetamine sulfate showed promise as an alternative. This case report highlights its potential when other ADHD medications are unavailable or ineffective.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition impacting attention, hyperactivity, and impulsivity.
- Central Nervous System (CNS) psychostimulants are the primary pharmacotherapy for ADHD.
- A persistent shortage of CNS psychostimulants since 2022 has disrupted ADHD treatment, affecting patient quality of life.
Related Concept Videos
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug Therapy
Antianxiety Medications
Oral Drug Delivery Systems: Continuous-Release Systems
Desensitization and Tachyphylaxis
Several...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Modified-Release Drug Delivery Systems: Overview
